Company / Gross Margin
CASTLE BIOSCIENCES INC Gross Margin History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
24.0%
FY2020
5-year range
-
FY2018-FY2020
Trend
-72.1%
vs FY2019
Sector context
#88 of 96
Health Care
What the data says
Among 96 Health Care companies, CASTLE BIOSCIENCES INC is in the bottom 8% for gross margin. Declined from 76.8% to 24.0% over the past 2 years.
Based on SEC 10-K filings.
24.0% in FY2020.
Declined from 76.8% to 24.0% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 96This company 24.0% Sector average 53.6%
▼
-55.2% below sector average
Key checks
Key Insights
- In FY2020, gross margin decreased 72.1% year-over-year.
- Currently 29.6pp below the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | 24.0% | -72.1% |
| FY2019 | 85.9% | +11.9% |
| FY2018 | 76.8% | - |
As of FY2020 · SEC 10-K · Updated Jul 4, 2026